SAB BIO
Working to transform treatment for people living with type 1 diabetes through a unique disease-modifying therapy
88 employees · est. 2014 · Miami, United States
True North Therapeutics is the older company (2014 vs 2013); SAB BIO is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | SAB BIO | True North Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2013 older |
| Headquarters | ||
| Headquarters | Miami, United States | Not tracked yet |
| Employees | ||
| Employees | 88 larger | 2 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Series Unknown |
| Total Funding | ||
| Total Funding | $186.32M | $142.00M |
| Funding Rounds | ||
| Funding Rounds | 7 | 5 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Immunotherapy, Type 1 Diabetes, Clinical-stage, Disease-modifying, Antibody Therapeutics, Immunoglobulins, Antibody Science, Immunology, Autoimmune Diseases, Public Health, Rare Conditions, Long-term Diseases, Pandemic Threats | Monoclonal Antibody, Complement Pathway, Rare Diseases, Hematologic Diseases, Renal Diseases, Neurological Diseases, Phagocytosis, Inflammation, Cell Lysis, Drug Development, Spin-out Company, IPierian, Antibody Therapy, Clinical Need |
| Website | ||
| Website | sab.bio | truenorthrx.com |
About SAB BIO
SAb Biotherapeutics is a biotechnology startup founded in 2014 and headquartered in the United States. The company is dedicated to developing a disease-modifying immunotherapy aimed at delaying the onset and progression of type 1 diabetes. They have a novel immunotherapy platform focused on developi...
About True North Therapeutics
True North Therapeutics is a pioneering biotechnology company founded in 2013 with a mission to selectively inhibit the Complement pathway for diseases of high unmet clinical need. The company's lead monoclonal antibody, TNT009, targets the Classical Complement pathway, enabling selective inhibition...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at SAB BIO and True North Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at SAB BIO and True North Therapeutic... — by email.
Frequently Asked Questions
Compare SAB BIO with someone else
Start typing a company name or domain.